Results 251 to 260 of about 442,339 (288)

Associations of genetically predicted interleukin-6 and tumor necrosis factor signaling pathways with mortality among persons with colorectal cancer: a two-sample Mendelian randomization. [PDF]

BMC Med
Bouka M, Nimptsch K, Pham TT, Bouras E, Kanellopoulou A, Phipps AI, Van Guelpen B, Brenner H, Li L, Le Marchand L, Tsilidis KK, Pischon T.   +11 more
europepmc   +1 more source

Translational relevance of animal models available on brain arteriovenous malformations, a systematic review. [PDF]

J Cereb Blood Flow Metab
Keränen S, Aquarius R, Frösen J, Hooijmans CR, Boogaarts HD.   +4 more
europepmc   +1 more source

Cytoplasmic tail diversity determines the effector bias of the adhesion GPCR ADGRL2. [PDF]

Cell Chem Biol
Garbett KA, Zheng C, Drube J, Hoffmann C, Gurevich VV, Sando RC.   +5 more
europepmc   +1 more source

The Impact on Systematic Reviews of Risk of Bias Assessment Changes From Conference Abstracts to Full Text. [PDF]

Cochrane Evid Synth Methods
Kenny RPW, Twentyman K, Craig D, Meader N, Norman G.   +4 more
europepmc   +1 more source

Omics-Derived Prognostic Biomarkers in Tongue Squamous Cell Carcinoma: A Systematic Review with Risk-of-Bias Appraisal and Translational Prioritization. [PDF]

Curr Issues Mol Biol
Astreidis I, Kostidis I, Malousi A, Paraskevopoulos K, Andreadis D, Vahtsevanos K, Vizirianakis I.   +6 more
europepmc   +1 more source

Ligand bias in receptor tyrosine kinase signaling [PDF]

Journal of Biological Chemistry, 2020
Ligand bias is the ability of ligands to differentially activate certain receptor signaling responses compared with others. It reflects differences in the responses of a receptor to specific ligands and has implications for the development of highly specific therapeutics.
Kelly Karl, Michael D Paul, Elena B Pasquale   +2 more
exaly   +3 more sources